PlexusDx vs Hims & Hers: GLP-1 Prepayment Compared Head-to-Head

Last reviewed: September 6, 2026 Last updated: September 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Hims & Hers advertises compounded semaglutide injection at a six-month prepaid rate of $199 per month—but you pay $1,194 upfront to start (verified checkout September 4, 2026). PlexusDx charges $189 per month on a true month-to-month plan with no upfront commitment, or $149 per month if you choose a six-month commitment billed monthly—not prepaid. Over twelve months the PlexusDx six-month commitment costs $1,788 total versus $2,388 for two Hims & Hers six-month cycles, a $600 difference. The central trade-off is prepayment obligation against billing flexibility and recurring cost.

At-a-glance comparison: compounded semaglutide injection

Prepayment versus month-to-month: the $1,194 upfront obligation

Hims & Hers markets compounded semaglutide injection at a six-month prepaid rate of $199 per month, but the verified checkout flow (captured September 4, 2026) requires a six-month prepayment of $1,194 to begin. That works out to $199 per month over six months, but the entire amount is due at signup—not billed monthly. If you complete two six-month cycles to reach twelve months of treatment, you will have paid $1,194 upfront twice, for a total outlay of $2,388 over the year.

PlexusDx bills monthly in every plan tier. The true month-to-month rate for compounded semaglutide injection is $189 per month with no contract and no upfront payment. If you prefer a lower per-month rate and are comfortable committing to six months, PlexusDx charges $149 per month billed monthly—still no prepayment. Over twelve months that six-month commitment plan costs $149 × 12 = $1,788 total, compared with $2,388 for the same period on Hims & Hers' prepaid model. The difference is $600 over one year (our calculation).

The Hims & Hers six-month prepayment structure eliminates month-to-month flexibility. If your clinical response, side-effect profile, or financial situation changes three months in, you have already paid for the full six months. PlexusDx monthly billing preserves the option to pause or stop without forfeiting future months you have prepaid. That structural difference may matter more than the per-month rate itself, depending on how certain you are about tolerance and continuation.

Like-for-like plan comparison: six-month commitment

Both programs offer a six-month plan for compounded semaglutide injection. Hims & Hers charges $1,194 upfront for six months (a six-month prepaid rate of $199 per month, captured September 4, 2026). PlexusDx charges $149 per month on a six-month commitment, billed monthly, for a six-month total of $894. That is a $300 difference over six months, or $600 over twelve months if you renew (our calculation).

The PlexusDx six-month commitment does not require prepayment—you are billed $149 each month for six consecutive months. If you need to stop at month four for any reason, you have paid only for the four months you received. The Hims & Hers model collects the full $1,194 before the first dose ships.

Three-month and month-to-month options

The verified Hims & Hers checkout data (September 4, 2026) shows only the six-month prepaid plan for compounded semaglutide injection. No month-to-month or three-month option was captured at checkout; confirm current availability directly with Hims & Hers if shorter commitment terms matter to your decision.

PlexusDx publishes three commitment tiers for compounded semaglutide injection, all billed monthly:

• Month-to-month: $189 per month, cancel anytime.
• Three-month commitment: $169 per month billed monthly for three months, then renews at the same rate if you continue.
• Six-month commitment: $149 per month billed monthly for six months, then renews at the same rate if you continue.

Over twelve months the three tiers cost $2,268 (month-to-month), $2,028 (three-month), and $1,788 (six-month) respectively (our calculation). Every tier includes the prescriber visit, medication compounded at a licensed 503A pharmacy, and shipping in the published price—no separate membership or service fee.

Dose titration and same-price guarantee

PlexusDx charges the same monthly rate at every semaglutide dose—your $189, $169, or $149 per month does not increase when your prescriber raises your dose from 0.25 mg to 0.5 mg, 1 mg, or higher. That same-dose-price policy is a published feature of every PlexusDx GLP-1 plan.

Hims & Hers pricing verification did not capture dose-specific rates; the advertised six-month prepaid rate of $199 per month may apply to starting doses, and higher doses may carry different pricing. Confirm dose-titration pricing at checkout or with Hims & Hers support if you expect to move beyond introductory doses.

Review volume and reported service themes

Hims & Hers shows 10,094 reviews on Trustpilot (captured September 4, 2026). The numeric star rating was not captured in the dataset, so a direct rating comparison is not possible. A sample pass of one- and two-star Trustpilot reviews and Reddit posts surfaced individual reports alleging perceived lack of efficacy, side effects, and regret after uncancelled renewals. These are anecdotal allegations—they do not represent verified facts or typical outcomes, and they may reflect a small fraction of the total user base given the high review volume.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026). The PlexusDx review sample is smaller than Hims & Hers' 10,000-plus review count, but the published rating provides a baseline quality signal. The comparative review picture is incomplete without a numeric Hims & Hers rating; treat review themes as directional indicators, not definitive verdicts, and confirm current ratings on Trustpilot before making service-quality assumptions.

Medication scope: semaglutide only in this comparison

This comparison covers compounded semaglutide injection only. Hims & Hers also markets branded weight-management medications (Wegovy, Ozempic, Zepbound, Mounjaro) and oral GLP-1 options, but checkout-verified pricing for those products was not captured in the dataset and cannot be compared here. Tirzepatide pricing for Hims & Hers was flagged for verification recheck and is excluded from this analysis.

PlexusDx offers compounded tirzepatide injection ($289 month-to-month, $269 on three-month commitment, $249 on six-month commitment), oral semaglutide capsules ($289/$269/$249), oral tirzepatide capsules ($349/$299/$279), and a microdose semaglutide injection maintenance protocol ($129 month-to-month). If you are comparing tirzepatide or oral options, request current Hims & Hers checkout totals and match them against the published PlexusDx rates for an apples-to-apples decision.

What prepayment buys—and what it costs

Prepayment can simplify budgeting if you are certain about six-month continuation: one transaction, no monthly billing reminders, no risk of a missed payment interrupting shipment. For some users that administrative simplicity justifies locking in $1,194 upfront.

The trade-off is financial flexibility. If you experience intolerable nausea at week two, hit your goal weight at month four, or face an unexpected expense that makes continuing unsustainable, the prepaid model offers no mid-cycle exit without forfeiting the unused months you have already funded. Monthly billing preserves the option to stop, pause, or switch without sunk cost.

The second trade-off is absolute cost. Even comparing six-month plans directly—Hims & Hers' prepaid $1,194 versus PlexusDx's $149/month commitment billed monthly—the PlexusDx plan costs $894 over six months, $300 less than the Hims & Hers prepaid total. Over twelve months the gap widens to $600 (our calculation). Prepayment does not deliver a lower price in this comparison; it delivers a higher total cost with less flexibility.

Choose Hims & Hers if…

You prefer a single upfront transaction and are confident you will continue semaglutide for at least six months without interruption. The $1,194 prepayment eliminates monthly billing cycles, and Hims & Hers' high review volume on Trustpilot indicates an established user base, even though the numeric rating was not captured in this dataset. If you value the administrative simplicity of one payment over cost savings and mid-cycle exit flexibility, and you have verified current checkout terms directly with Hims & Hers, the prepaid structure may fit your preference.

Choose PlexusDx if…

You want monthly billing with no upfront payment, a lower per-month cost on every commitment tier, and the flexibility to stop or pause without forfeiting prepaid months. PlexusDx charges $189 per month with no contract, $169 per month on a three-month commitment, or $149 per month on a six-month commitment—all billed monthly, never prepaid. The same rate applies at every dose, and the 4.3-star Trustpilot rating with 83% of reviews at four stars or higher provides transparent service-quality evidence. Over twelve months the six-month commitment saves you $600 compared with two Hims & Hers six-month prepaid cycles (our calculation), and you retain the option to stop at any monthly billing point if your clinical picture or financial situation changes.

Methodology and freshness

Hims & Hers pricing was verified by checkout capture on September 4, 2026; PlexusDx pricing was verified on September 6, 2026. The $1,194 six-month upfront figure for Hims & Hers compounded semaglutide injection and the six-month prepaid rate of $199 per month are drawn from that checkout session. The PlexusDx rates—$189 month-to-month, $169 on three-month commitment, $149 on six-month commitment—are current published prices as of the same capture window.

The 12-month cost calculations are our arithmetic: Hims & Hers $1,194 × 2 six-month cycles = $2,388; PlexusDx $149/month × 12 months = $1,788; difference $2,388 − $1,788 = $600. All derived figures are labeled "our calculation" in the text.

Hims & Hers Trustpilot review count (10,094) and negative themes (perceived lack of efficacy, side effects, regret after uncancelled renewal) were captured September 4, 2026, from a sample pass of one- and two-star reviews and Reddit posts. The numeric star rating was not captured and cannot be compared. PlexusDx Trustpilot rating (4.3 stars, 79% five-star, 83% four stars or higher) was captured September 9, 2026.

Tirzepatide and branded medication pricing for Hims & Hers were not verified at checkout and are excluded. Oral GLP-1 options were noted as available but not priced in the dataset. Confirm current product availability, pricing, and prepayment terms at checkout before committing to either program.

Frequently Asked Questions

Does Hims & Hers require $1,194 upfront for every semaglutide plan?

The verified checkout data from September 4, 2026, shows a six-month prepayment of $1,194 for compounded semaglutide injection. No month-to-month or shorter-commitment option was captured in that session. Confirm current plan options and payment terms directly with Hims & Hers at checkout.

Can I get a refund if I stop Hims & Hers semaglutide after two months?

Refund and cancellation policies were not captured in the pricing verification. Because the $1,194 is paid upfront for six months, ask Hims & Hers support about mid-cycle cancellation terms and any prorated refund eligibility before you pay.

Does PlexusDx charge more per month when my semaglutide dose increases?

No. PlexusDx publishes the same monthly rate at every dose for each plan tier. If you are on the $189 month-to-month plan, you pay $189 whether your prescriber has you at 0.25 mg or 2.4 mg. The same policy applies to the three-month and six-month commitment rates.

How does PlexusDx $149/month compare with the Hims & Hers six-month prepaid plan?

Both are six-month plans, but Hims & Hers requires $1,194 upfront (a six-month prepaid rate of $199/month) while PlexusDx bills $149 per month over six months with no prepayment. Over six months PlexusDx costs $894 total versus $1,194 for Hims & Hers—a $300 difference. Over twelve months the gap is $600 (our calculation).

Which program has better reviews, Hims & Hers or PlexusDx?

PlexusDx holds a verified 4.3-star Trustpilot rating with 83% of reviews at four stars or higher (captured September 9, 2026). Hims & Hers has 10,094 Trustpilot reviews, but the numeric rating was not captured in the dataset. Review volume favors Hims & Hers; the only verified numeric rating in this comparison is PlexusDx's 4.3 stars.

Sources

• PlexusDx published pricing for compounded semaglutide injection (month-to-month, three-month, and six-month commitment rates), accessed September 6, 2026.
• Hims & Hers checkout verification for compounded semaglutide injection six-month prepaid plan ($1,194 upfront, six-month prepaid rate of $199/month), captured September 4, 2026.
• Hims & Hers Trustpilot review count and negative-theme sample pass (perceived lack of efficacy, side effects, uncancelled renewal regret), captured September 4, 2026.
• PlexusDx Trustpilot rating (4.3 stars, 79% five-star, 83% four stars or higher), captured September 9, 2026.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.